BIOA
BioAge Labs, Inc.
24.77
1 x 17.77
1 x 31.55
bid
ask
+
0.50
2.08%
11:24 AM
timesize
| Ytd | 87.19% | |
| 1y | 484.08% |
24.11
day range
25.06
4.11
52 week range
25.80
| Open | 24.43 | Prev Close | 24.26 | Low | 24.11 | High | 25.06 | Mkt Cap | 1.10B |
| Vol | 87.08K | Avg Vol | 495.56K | EPS | -2.40 | P/E | N/A | Forward P/E | -11.78 |
| Beta | 4.26 | Short Ratio | 4.63 | Inst. Own | 85.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 18.36 | 200-d Avg | 14.74 | 1yr Est | 49.50 |
| Income Statement | |||
| Total Revenue | 2.77M | ||
| Revenues (USD) | 2.77M | ||
| Gross Profit | 2.77M | ||
| Operating Expenses | 28.15M | ||
| Research and Development Expense | 20.41M | ||
| Selling, General and Administrative Expense | 7.74M | ||
| Operating Income | -25.37M | ||
| Interest Expense | 39.00K | ||
| Net Income | -22.25M | ||
| Net Income Common Stock | -22.25M | ||
| Net Income Common Stock (USD) | -22.25M | ||
| Consolidated Income | -22.25M | ||
| Earnings per Basic Share | -0.52 | ||
| Earnings per Basic Share (USD) | -0.52 | ||
| Earnings per Diluted Share | -0.52 | ||
| Earning Before Interest & Taxes (EBIT) | -22.21M | ||
| Earning Before Interest & Taxes (USD) | -22.21M | ||
| Weighted Average Shares | 42.48M | ||
| Weighted Average Shares Diluted | 42.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 241.78M | ||
| Cash and Equivalents (USD) | 241.78M | ||
| Investments | 143.20M | ||
| Investments Current | 141.42M | ||
| Investments Non-Current | 1.78M | ||
| Trade and Non-Trade Receivables | 709.00K | ||
| Current Assets | 391.86M | ||
| Property, Plant & Equipment Net | 3.80M | ||
| Total Assets | 397.65M | ||
| Debt Current | 1.81M | ||
| Total Debt | 4.03M | ||
| Current Liabilities | 15.83M | ||
| Debt Non-Current | 2.23M | ||
| Total Liabilities | 18.53M | ||
| Accumulated Retained Earnings (Deficit) | -355.67M | ||
| Accumulated Other Comprehensive Income | 73.00K | ||
| Shareholders Equity | 379.12M | ||
| Shareholders Equity (USD) | 379.12M | ||
| Assets Non-Current | 5.79M | ||
| Total Debt (USD) | 4.03M | ||
| Deferred Revenue | 6.19M | ||
| Liabilities Non-Current | 2.71M | ||
| Trade and Non-Trade Payables | 3.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 128.00K | ||
| Net Cash Flow from Financing | 123.72M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 52.89M | ||
| Capital Expenditure | -26.00K | ||
| Issuance (Purchase) of Equity Shares | 125.31M | ||
| Issuance (Repayment) of Debt Securities | -1.50M | ||
| Net Cash Flow from Investing | -46.75M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -46.73M | ||
| Net Cash Flow from Operations | -24.05M | ||
| Effect of Exchange Rate Changes on Cash | -27.00K | ||
| Share Based Compensation | 4.26M | ||